Between-center and between-country differences in outcome after aneurysmal subarachnoid hemorrhage in the Subarachnoid Hemorrhage International Trialists (SAHIT) repository

View More View Less
  • 1 Departments of Public Health,
  • 5 Intensive Care,
  • 6 Neurology, and
  • 7 Radiology and Nuclear Medicine, Erasmus MC–University Medical Center, Rotterdam;
  • 12 Department of Critical Care, University Medical Center Groningen, University of Groningen, Groningen;
  • 19 Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden;
  • 8 Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands;
  • 2 Division of Neurosurgery and
  • 3 Neuroscience Research Program, Li Ka Shing Knowledge Institute, and
  • 13 Decision Neuroscience Unit, Division of Neurology, St. Michael’s Hospital, University of Toronto;
  • 4 Institute of Medical Science and
  • 16 Department of Surgery, University of Toronto, Toronto, Ontario;
  • 18 Departments of Neurology, Neurosurgery, and Critical Care, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada;
  • 9 Departments of Anesthesiology and Critical Care Medicine, Neurology, and Neurosurgery, Johns Hopkins University, Baltimore, Maryland;
  • 10 Department of Epidemiology, University of Iowa College of Public Health, Iowa City, Iowa;
  • 11 Department of Anesthesiology, University of Minnesota Medical School, Minneapolis, Minnesota;
  • 17 Department of Neurology, Henry Ford Health System, Detroit, Michigan; and
  • 14 Department of Neurosurgery and
  • 15 Section for Diagnostic and Interventional Neuroradiology, Department of Radiology, Basel University Hospital, University of Basel, Basel, Switzerland
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

OBJECTIVE

Differences in clinical outcomes between centers and countries may reflect variation in patient characteristics, diagnostic and therapeutic policies, or quality of care. The purpose of this study was to investigate the presence and magnitude of between-center and between-country differences in outcome after aneurysmal subarachnoid hemorrhage (aSAH).

METHODS

The authors analyzed data from 5972 aSAH patients enrolled in randomized clinical trials of 3 different treatments from the Subarachnoid Hemorrhage International Trialists (SAHIT) repository, including data from 179 centers and 20 countries. They used random effects logistic regression adjusted for patient characteristics and timing of aneurysm treatment to estimate between-center and between-country differences in unfavorable outcome, defined as a Glasgow Outcome Scale score of 1–3 (severe disability, vegetative state, or death) or modified Rankin Scale score of 4–6 (moderately severe disability, severe disability, or death) at 3 months. Between-center and between-country differences were quantified with the median odds ratio (MOR), which can be interpreted as the ratio of odds of unfavorable outcome between a typical high-risk and a typical low-risk center or country.

RESULTS

The proportion of patients with unfavorable outcome was 27% (n = 1599). The authors found substantial between-center differences (MOR 1.26, 95% CI 1.16–1.52), which could not be explained by patient characteristics and timing of aneurysm treatment (adjusted MOR 1.21, 95% CI 1.11–1.44). They observed no between-country differences (adjusted MOR 1.13, 95% CI 1.00–1.40).

CONCLUSIONS

Clinical outcomes after aSAH differ between centers. These differences could not be explained by patient characteristics or timing of aneurysm treatment. Further research is needed to confirm the presence of differences in outcome after aSAH between hospitals in more recent data and to investigate potential causes.

ABBREVIATIONS aSAH = aneurysmal subarachnoid hemorrhage; CI = confidence interval; GOS = Glasgow Outcome Scale; IHAST = Intraoperative Hypothermia for Aneurysm Surgery Trial; IQR = interquartile range; MASH = Magnesium Sulfate in Aneurysmal Subarachnoid Hemorrhage; MOR = median odds ratio; mRS = modified Rankin Scale; RCT = randomized clinical trial; SAHIT = Subarachnoid Hemorrhage International Trialists; TBI = traumatic brain injury; WFNS = World Federation of Neurosurgical Societies.

Supplementary Materials

    • Supplemental Content (PDF 692 KB)

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Correspondence Simone Dijkland: Erasmus MC–University Medical Center, Rotterdam, The Netherlands. s.dijkland@erasmusmc.nl.

INCLUDE WHEN CITING Published online August 23, 2019; DOI: 10.3171/2019.5.JNS19483.

Disclosures R.L.M. reports grants from the Brain Aneurysm Foundation, the Heart and Stroke Foundation of Canada, and Genome Canada outside the present workhaving a patent on a drug delivery system for treatment of cerebral vasospasm issued; and having been Chief Scientific Officer and an employee of Edge Therapeutics, Inc. J.I.S. reports grants from PCORI and support from BARD and Neurocritical Care Society outside the present work. S.A.M. reports personal fees from Idorsia Pharmaceuticals and Edge Therapeutics outside the present work. M.D.C. reports grants from Cancer Care Ontario, Canadian Institute for Military and Veteran Health Research, Mitacs Canada, Physicians’ Services Inc. Foundation, and Academic Health Science Center Alternative Funding Plan outside the present work. G.S. is Associate Editor of the Emerging Therapies Section of Stroke.

  • 1

    Austin PC, Merlo J: Intermediate and advanced topics in multilevel logistic regression analysis. Stat Med 36:32573277, 2017

  • 2

    Bayman EO, Chaloner KM, Hindman BJ, Todd MM: Bayesian methods to determine performance differences and to quantify variability among centers in multi-center trials: the IHAST trial. BMC Med Res Methodol 13:5, 2013

    • Search Google Scholar
    • Export Citation
  • 3

    Boogaarts HD, van Amerongen MJ, de Vries J, Westert GP, Verbeek AL, Grotenhuis JA, : Caseload as a factor for outcome in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Neurosurg 120:605611, 2014

    • Search Google Scholar
    • Export Citation
  • 4

    Citerio G, Gaini SM, Tomei G, Stocchetti N: Management of 350 aneurysmal subarachnoid hemorrhages in 22 Italian neurosurgical centers. Intensive Care Med 33:15801586, 2007

    • Search Google Scholar
    • Export Citation
  • 5

    Connolly ES Jr, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, : Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 43:17111737, 2012

    • Search Google Scholar
    • Export Citation
  • 6

    Dijkland SA, Roozenbeek B, Brouwer PA, Lingsma HF, Dippel DW, Vergouw LJ, : Prediction of 60-day case fatality after aneurysmal subarachnoid hemorrhage: external validation of a prediction model. Crit Care Med 44:15231529, 2016

    • Search Google Scholar
    • Export Citation
  • 7

    Dorhout Mees SM, Algra A, Vandertop WP, van Kooten F, Kuijsten HA, Boiten J, : Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial. Lancet 380:4449, 2012 (Errata in Lancet 380:28, 2012; Lancet 380:1994, 2012)

    • Search Google Scholar
    • Export Citation
  • 8

    Egawa S, Hifumi T, Kawakita K, Okauchi M, Shindo A, Kawanishi M, : Impact of neurointensivist-managed intensive care unit implementation on patient outcomes after aneurysmal subarachnoid hemorrhage. J Crit Care 32:5255, 2016

    • Search Google Scholar
    • Export Citation
  • 9

    Fargen KM, Soriano-Baron HE, Rushing JT, Mack W, Mocco J, Albuquerque F, : A survey of intracranial aneurysm treatment practices among United States physicians. J Neurointerv Surg 10:4449, 2018

    • Search Google Scholar
    • Export Citation
  • 10

    Gray LJ, Sprigg N, Bath PM, Sørensen P, Lindenstrøm E, Boysen G, : Significant variation in mortality and functional outcome after acute ischaemic stroke between Western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST). J Neurol Neurosurg Psychiatry 77:327333, 2006

    • Search Google Scholar
    • Export Citation
  • 11

    Gritti P, Akeju O, Lorini FL, Lanterna LA, Brembilla C, Bilotta F: A narrative review of adherence to subarachnoid hemorrhage guidelines. J Neurosurg Anesthesiol 30:203216, 2018

    • Search Google Scholar
    • Export Citation
  • 12

    Guo G, Zhao H: Multilevel modeling for binary data. Annu Rev Sociol 26:441462, 2000

  • 13

    Haley EC Jr, Kassell NF, Apperson-Hansen C, Maile MH, Alves WM: A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America. J Neurosurg 86:467474, 1997

    • Search Google Scholar
    • Export Citation
  • 14

    Harrison DA, Prabhu G, Grieve R, Harvey SE, Sadique MZ, Gomes M, : Risk Adjustment In Neurocritical care (RAIN)—prospective validation of risk prediction models for adult patients with acute traumatic brain injury to use to evaluate the optimum location and comparative costs of neurocritical care: a cohort study. Health Technol Assess 17:vii–viii, 1–350, 2013

    • Search Google Scholar
    • Export Citation
  • 15

    Hollingworth M, Chen PR, Goddard AJ, Coulthard A, Söderman M, Bulsara KR: Results of an international survey on the investigation and endovascular management of cerebral vasospasm and delayed cerebral ischemia. World Neurosurg 83:11201126, 1126.e1, 2015

    • Search Google Scholar
    • Export Citation
  • 16

    Jaja BN, Attalla D, Macdonald RL, Schweizer TA, Cusimano MD, Etminan N, : The Subarachnoid Hemorrhage International Trialists (SAHIT) repository: advancing clinical research in subarachnoid hemorrhage. Neurocrit Care 21:551559, 2014

    • Search Google Scholar
    • Export Citation
  • 17

    Jaja BN, Cusimano MD, Etminan N, Hanggi D, Hasan D, Ilodigwe D, : Clinical prediction models for aneurysmal subarachnoid hemorrhage: a systematic review. Neurocrit Care 18:143153, 2013

    • Search Google Scholar
    • Export Citation
  • 18

    Jaja BN, Lingsma H, Schweizer TA, Thorpe KE, Steyerberg EW, Macdonald RL: Prognostic value of premorbid hypertension and neurological status in aneurysmal subarachnoid hemorrhage: pooled analyses of individual patient data in the SAHIT repository. J Neurosurg 122:644652, 2015

    • Search Google Scholar
    • Export Citation
  • 19

    Jaja BNR, Saposnik G, Lingsma HF, Macdonald E, Thorpe KE, Mamdani M, : Development and validation of outcome prediction models for aneurysmal subarachnoid haemorrhage: the SAHIT multinational cohort study. BMJ 360:j5745, 2018

    • Search Google Scholar
    • Export Citation
  • 20

    Kassell NF, Haley EC Jr, Apperson-Hansen C, Alves WM: Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand. J Neurosurg 84:221228, 1996

    • Search Google Scholar
    • Export Citation
  • 21

    Larsen K, Merlo J: Appropriate assessment of neighborhood effects on individual health: integrating random and fixed effects in multilevel logistic regression. Am J Epidemiol 161:8188, 2005

    • Search Google Scholar
    • Export Citation
  • 22

    Lingsma HF, Roozenbeek B, Li B, Lu J, Weir J, Butcher I, : Large between-center differences in outcome after moderate and severe traumatic brain injury in the international mission on prognosis and clinical trial design in traumatic brain injury (IMPACT) study. Neurosurgery 68:601608, 2011

    • Search Google Scholar
    • Export Citation
  • 23

    Lingsma HF, Steyerberg EW, Eijkemans MJ, Dippel DW, Scholte Op Reimer WJ, Van Houwelingen HC: Comparing and ranking hospitals based on outcome: results from The Netherlands Stroke Survey. QJM 103:99108, 2010

    • Search Google Scholar
    • Export Citation
  • 24

    Lipsman N, Tolentino J, Macdonald RL: Effect of country or continent of treatment on outcome after aneurysmal subarachnoid hemorrhage. Clinical article. J Neurosurg 111:6774, 2009

    • Search Google Scholar
    • Export Citation
  • 25

    Maas AI, Menon DK, Steyerberg EW, Citerio G, Lecky F, Manley GT, : Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI): a prospective longitudinal observational study. Neurosurgery 76:6780, 2015

    • Search Google Scholar
    • Export Citation
  • 26

    Macdonald RL: Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol 10:4458, 2014

  • 27

    Merlo J, Chaix B, Ohlsson H, Beckman A, Johnell K, Hjerpe P, : A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Community Health 60:290297, 2006

    • Search Google Scholar
    • Export Citation
  • 28

    Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ: Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 8:635642, 2009

    • Search Google Scholar
    • Export Citation
  • 29

    Pandey AS, Gemmete JJ, Wilson TJ, Chaudhary N, Thompson BG, Morgenstern LB, : High subarachnoid hemorrhage patient volume associated with lower mortality and better outcomes. Neurosurgery 77:462470, 2015

    • Search Google Scholar
    • Export Citation
  • 30

    Ridwan S, Urbach H, Greschus S, von Hagen J, Esche J, Boström A: Health care costs of spontaneous aneurysmal subarachnoid hemorrhage for rehabilitation, home care, and in-hospital treatment for the first year. World Neurosurg 97:495500, 2017

    • Search Google Scholar
    • Export Citation
  • 31

    Rinkel GJ, Algra A: Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage. Lancet Neurol 10:349356, 2011

  • 32

    Steiner T, Juvela S, Unterberg A, Jung C, Forsting M, Rinkel G: European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis 35:93112, 2013

    • Search Google Scholar
    • Export Citation
  • 33

    Suarez JI, Zaidat OO, Suri MF, Feen ES, Lynch G, Hickman J, : Length of stay and mortality in neurocritically ill patients: impact of a specialized neurocritical care team. Crit Care Med 32:23112317, 2004

    • Search Google Scholar
    • Export Citation
  • 34

    Todd MM, Hindman BJ, Clarke WR, Torner JC: Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med 352:135145, 2005

    • Search Google Scholar
    • Export Citation
  • 35

    van den Bergh WM, Algra A, van Kooten F, Dirven CM, van Gijn J, Vermeulen M, : Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke 36:10111015, 2005

    • Search Google Scholar
    • Export Citation
  • 36

    van Essen TA, den Boogert HF, Cnossen MC, de Ruiter GCW, Haitsma I, Polinder S, : Variation in neurosurgical management of traumatic brain injury: a survey in 68 centers participating in the CENTER-TBI study. Acta Neurochir (Wien) 161:435449, 2019

    • Search Google Scholar
    • Export Citation
  • 37

    Velly LJ, Bilotta F, Fàbregas N, Soehle M, Bruder NJ, Nathanson MH: Anaesthetic and ICU management of aneurysmal subarachnoid haemorrhage: a survey of European practice. Eur J Anaesthesiol 32:168176, 2015

    • Search Google Scholar
    • Export Citation

Metrics